Literature DB >> 19230731

A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor.

Gary Tresadern1, Daniele Bemporad, Trevor Howe.   

Abstract

Ligand based virtual screening approaches were applied to the CRF1 receptor. We compared ECFP6 fingerprints, FTrees, Topomers, Cresset FieldScreen, ROCS OpenEye shape Tanimoto, OpenEye combo-score and OpenEye electrostatics. The 3D methods OpenEye Shape Tanimoto, combo-score and Topomers performed the best at separating actives from inactives in retrospective experiments. By virtue of their higher enrichment the same methods identified more active scaffolds. However, amongst a given number of active compounds the Cresset and OpenEye electrostatic methods contained more scaffolds and returned ranked compounds with greater diversity. A selection of the methods were employed to recommend compounds for screening in a prospective experiment. New CRF1 actives antagonists were found. The new actives contained different underlying chemical architecture to the query molecules, results indicative of successful scaffold-hopping.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230731     DOI: 10.1016/j.jmgm.2009.01.003

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  15 in total

1.  Tautomers and topomers: challenging the uncertainties of direct physicochemical modeling.

Authors:  Richard D Cramer
Journal:  J Comput Aided Mol Des       Date:  2010-03-21       Impact factor: 3.686

2.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

3.  Computation of 3D queries for ROCS based virtual screens.

Authors:  Gregory J Tawa; J Christian Baber; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2009-09-26       Impact factor: 3.686

4.  Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels.

Authors:  Y Majeed; A K Agarwal; J Naylor; V A L Seymour; S Jiang; K Muraki; C W G Fishwick; D J Beech
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Ligand-based virtual screening approach using a new scoring function.

Authors:  Adel Hamza; Ning-Ning Wei; Chang-Guo Zhan
Journal:  J Chem Inf Model       Date:  2012-04-09       Impact factor: 4.956

6.  Small molecule inhibitors of hantavirus infection.

Authors:  Pamela R Hall; Andrei Leitão; Chunyan Ye; Kathleen Kilpatrick; Brian Hjelle; Tudor I Oprea; Richard S Larson
Journal:  Bioorg Med Chem Lett       Date:  2010-09-19       Impact factor: 2.823

7.  Pharmacophore-based screening of diamidine small molecule inhibitors for protein arginine methyltransferases.

Authors:  Kun Qian; Chunli Yan; Hairui Su; Tran Dang; Bo Zhou; Zhenyu Wang; Xinyang Zhao; Ivaylo Ivanov; Meng-Chiao Ho; Y George Zheng
Journal:  RSC Med Chem       Date:  2020-09-30

8.  Structural properties of non-traditional drug targets present new challenges for virtual screening.

Authors:  Ragul Gowthaman; Eric J Deeds; John Karanicolas
Journal:  J Chem Inf Model       Date:  2013-08-13       Impact factor: 4.956

9.  Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft.

Authors:  Bradley R Kossmann; Monica Abdelmalak; Sophia Lopez; Gabrielle Tender; Chunli Yan; Yves Pommier; Christophe Marchand; Ivaylo Ivanov
Journal:  Bioorg Med Chem Lett       Date:  2016-05-24       Impact factor: 2.823

10.  Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1H-benzimidazol-2-ones as mGlu2 Receptor PAMs.

Authors:  Ana Isabel de Lucas; Juan Antonio Vega; Encarnación Matesanz; María Lourdes Linares; Aránzazu García Molina; Gary Tresadern; Hilde Lavreysen; Andrés A Trabanco; José María Cid
Journal:  ACS Med Chem Lett       Date:  2019-10-10       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.